SYDNEY: Biotron Limited (ASX:BIT) announced Wednesday it will acquire Sedarex Limited, a company holding global patents for SedRx™, a next-generation general anaesthetic, in a transaction supported by a $2.5 million capital raising. The acquisition includes an initial issuance of 500 million Biotron shares, valued at $1.5 million, with additional milestone-linked shares tied to regulatory and…
LONDON: Diaceutics PLC (AIM: DXRX), a technology provider for pharmaceutical and biotech companies, announced strong first-half revenue growth driven by increased demand for its precision medicine commercialization services. Revenue rose 22% on a constant currency basis to £14.6 million ($18.9 million) in H1 2025, marking a three-year compound annual growth rate of 25%. Recurring revenue…
LONDON: N4 Pharma plc (AIM: N4P), a UK-based biotechnology company developing its proprietary Nuvec® gene delivery system for advanced cancer and disease therapies, announced its audited financial results for the year ended Dec. 31, 2024. The company’s annual report and notice of its annual general meeting (AGM) have been distributed to shareholders. The AGM will…
OSLO, NORWAY: Nordic Nanovector ASA (OSE: NANOV) announced the appointment of Dr Sandra Jonsson, PhD, MBA as Chief Operating Officer. Dr Sandra Jonsson will start on 10 January 2022 and takes over from Marco Renoldi, MD, who is retiring from the role but will remain as a consultant to the company. Dr Sandra Jonsson is…
Charles River Laboratories Inc., is an American corporation specializing in a variety of preclinical and clinical laboratory services for the pharmaceutical, medical device and biotechnology industries. It also supplies assorted biomedical products and research and development outsourcing services for use in the pharmaceutical industry. According to its website, its customers include leading pharmaceutical, biotechnology, agrochemical,…
WASHINGTON: AIDS Healthcare Foundation (AHF) called on the members of the U.S. House of Representatives Subcommittee on Oversight and Investigations to ask tough questions of drug companies testifying on coronavirus vaccines. Overpaid pharmaceutical company executives from AstraZeneca, Johnson & Johnson, Merck, Moderna and Pfizer will be testifying at a hearing “Pathway to a Vaccine: Efforts…
MOSCOW: Sistema PJSFC, a publicly traded diversified Russian holding company, announces the completion of the merger of pharmaceutical assets JSC Pharmaceutical Enterprise Obolenskoe (OBL Pharm) and JSC Binnopharm. The merged company will operate under the brand Alium. As a result of Sistema’s participation in an additional issue of OBL Pharm shares, Sistema’s effective stake in…